???global.info.a_carregar???
Mariana Gomes Morais has graduated in Biochemistry in 2015 and later concluded her masters in Oncology in 2017 by Abel Salazar Institute of Biomedical Sciences in Oporto University. Since 2018, she is a PhD student of Biomedical Sciences Doctoral Programme in Oporto University, having been granted a FCT Grant to conduct her studies. As a biochemistry graduated and master in Oncology, the area of her scientific activity is the Life Sciences, in particular, the field of molecular oncology. I have been working in the discovery of new circulating biomarkers of prognosis related to Warburg Effect in Renal Cell Carcinoma. Currently, she is interested in the potentiation of current therapies (using new technologies such as nanoparticles) in Urological Cancers in the hope of helping overcoming resistance. She has been a reseacher in the Moletular Oncology and Viral Pathology of The Investigation Center of Portuguese Oncology Institute of Oporto from 2015. Her focus has been in Urological Cancers, namely Renal Cell Carcinoma and Prostate Cancer. During her Masters, she developed her work in Warburg Effect characterization of urological cancer in hope to find potential biomarkers to help improve clincal practice of these tumors. In the last years, her PhD work focused in the application of Warburg Effect's knowledge to potentiate nanoparticles as therapeutic strategies to revert resistance in Prostate Cancer Resistant to Castration. She has published 11 papers, 5 of which as first author and published 1 book chapter. Additionally, she co-oriented 1 master studentand is currently co-orientating 1 bachelor's student. She is currently a member of the FCT funded project NanoWar2Cancer(PTDC/MED-QUI/29800/32017). KEYWORDS: Nanoparticles synthesis and characterization; Oncology; Cell CUlture; Microscopy; Nucleic acid purification and extraction; Conventional and Real Time PCR; Exosome Isolation; Protein Extraction adn quantification, Western Blotting.
Read full resume ↓
Identification

Personal identification

Full name
Mariana Gomes Morais

Citation names

  • Morais, Mariana

Author identifiers

Ciência ID
4215-FC71-B1B7
ORCID iD
0000-0001-8406-8210

Knowledge fields

  • Exact Sciences - Chemical Sciences
  • Natural sciences - Biological Sciences - Cell Biology
  • Natural sciences - Biological Sciences - Biochemistry
  • Natural sciences - Biological Sciences - Genetics and Heredity
  • Natural sciences - Biological Sciences - Microbiology
  • Natural sciences - Biological Sciences - Biophysics
  • Medical and Health Sciences - Clinical Medicine - Oncology
  • Natural sciences - Biological Sciences - Molecular Biology

Languages

Language Speaking Reading Writing Listening Peer-review
English Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
Portuguese (Mother tongue)
German Elementary (A2) Elementary (A2) Elementary (A2) Elementary (A2)
Education
Degree Classification
2018/07 - 2022
Ongoing
 Biomedical Sciences (Doctor of Philosophy)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Silver nanoparticles meet prostate cancer cells: the nano-medicine response to cancer treatment optimization" (THESIS/DISSERTATION)
2015/09 - 2017/12
Concluded
 Oncology (Master)
Major in Molecular Oncology
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"“Glut1-retaled micro-RNAs and Glycolysis in Clear Cell Renal Cell Carcinoma”" (THESIS/DISSERTATION)
 18
2012/09 - 2015/07
Concluded
 Bioquemistry (Licence)
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"VDR rs731236 and CYP2R1 rs2060793 genetic polymorphisms characterization in the North of Portugal¿s population: potential implication in the risk of developing Depression¿" (THESIS/DISSERTATION)
 16
Affiliation

Science

Category
Host institution 		Employer
2015 - Current Researcher (Research) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017/06/01 - 2020/09/30 Researcher (Research) Liga Portuguesa Contra o Cancro Núcleo Regional do Centro, Portugal
2015/01/02 - 2017/05/31 Research Trainee (Research) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Projects

Contract

Designation Funders
2018/08/01 - Current Sensitization of urologic tumors therapy driven by nanotechnology
PTDC/MED-QUI/29800/2017
Other
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

REQUIMTE LAQV Porto, Portugal
Ongoing
2019/01/01 - 2019/12/31 Centro de Investigação do Instituto Português de Oncologia do Porto
UID/DTP/00776/2019
UID/DTP/04750/2019
UIDB/04750/2020
UIDB/00776/2020
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade do Porto Instituto de Saúde Pública, Portugal

Universidade do Porto Unidade de Investigação em Epidemiologia, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Morais, Mariana; Guilherme Carvalho Dias, Francisca; Alexandre Velho Prior, João; Luísa Pereira Teixeira, Ana; Manuel de Medeiros Melo Silva, Rui. "The Impact of Oxidoreductases-Related MicroRNAs in Glucose Metabolism of Renal Cell Carcinoma and Prostate Cancer". In Oxidoreductase. IntechOpen, 2021.
    Published • 10.5772/intechopen.93932
Conference poster
  1. Tavares, Inês; Morais, Mariana; Dias, Francisca; Bidarra, Silvia; MEDEIROS, RUI; Teixeira, Ana Luísa. "Extracellular vesicles-derived microRNAs: mediators of enzalutamide resistance in Prostate Cancer". Paper presented in 1st Young Researchers Symposium - Portuguese Oncology Institute of Oncology of Porto Research Center, 2023.
  2. Teixeira, Ana Luísa; Dias, Francisca; Patrão, Ana; Morais, Mariana; Ferreira, Marta; Silva, Alexandra; Morais, António; et al. "Extracellular vesicles-AGO2-related microRNAs as potential prognosis biomarkers in clear-cell renal cell carcinoma". Paper presented in EACR 2023 Conference, 2023.
  3. Morais, Mariana; Figueiredo, Patrícia; Dias, Francisca; Tavares, Inês; Mikkonen, KS; Teixeira, Ana Luísa; MEDEIROS, RUI. "Caveolae-dependent endocytosis is responsible for the selective effect of Silver Nanoparticles in Prostate Cancer Sensitive and Resistant to Androgen Deprivation Therapy". Paper presented in EACR 2023 Conference, 2023.
  4. Morais, Mariana; Machado, Vera; Figueiredo, Patrícia; Dias, Francisca; Mikkonen, KS; Teixeira, Ana Luísa; MEDEIROS, RUI. "Nanopartículas de prata funcionalizadas com glucose como potenciais agentes terapêuticos em Cancro de Próstata resistente à Terapia de Bloqueio Androgénico". Paper presented in 3º Encontro Nacional de Jovens Investigadores em Oncologia, 2021.
  5. Tavares, Inês; Morais, Mariana; Dias, Francisca; Teixeira, Ana Luísa; MEDEIROS, RUI. "O efeito de Warburg no processo de aquisição de resistência à Terapia de Bloqueio Androgénico". Paper presented in 3º Encontro Nacional de Jovens Investigadores em Oncologia, 2021.
  6. Morais, Mariana; Machado, Vera; Dias, Francisca; Palmeira, Carlos; Martins, Gabriela; Fonseca, Magda; Martins, Catarina; et al. "The cytotoxic potential of starch-capped silver-nanoparticles (AgNPs) and their ability to induce cell cycle arrest in prostate cancer cells". Paper presented in XVII Congress of the Iberian Society of Cytometry ¿ SIC 2021, 2021.
  7. Morais, Mariana; Vera Machado; Francisca Dias; Magda Fonseca; Ana Luísa Teixeira; João Prior; Rui Medeiros. "O potencial citotóxico de nanopartículas de prata com cappingde amido no Cancro da Próstata Resistente à Castração". Paper presented in 16º Congresso Nacional de Oncologia, 2019.
  8. Teixeira, Ana Luísa; Dias, Francisca; Silva, Carlos; Morais, Mariana; Nogueira, Inês; Patrão, Sofia; Maurício, Joaquina; Medeiros, Rui. "SNPs no gene AGO2: influência nos níveis circulantes de mRNA e na progressão do carcinoma de células renais". Paper presented in 15º Congresso Nacional de Oncologia, 2019.
  9. Magda Fonseca; Ana Luísa Teixeira; Francisca Dias; Mariana Morais; Vera Machado; Rui Medeiros; João AV Prior. "Influence of the starch dissolution approach in the green synthesis of starch-capped silver nanoparticles". Paper presented in XXV Encontro Galego- Português de Química, 2019.
    10.1063/1.4810184
  10. Morais, Mariana; Francisca Dias; Telma Resende; Inês Nogueira; Jorge Oliveira; Joaquina Maurício; Ana Luísa Teixeira; Rui Medeiros. "Leukocyte telomere length and hTERT genetic polymorphism rs2735940 influence renal cell carcinoma clinical outcome". Paper presented in 11º Symposium on Metabolism, 2019.
  11. Morais, Mariana; Francisca Dias; Inês Nogueira; Anabela Leão; Nuno Gonçalves; Luís Araújo; Sara Granja; et al. "miR-144, miR-186 e GLUT-1: A desregulação do metabolismo das células tumorais e o Carcinoma das Células Renais de células claras". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, 2019.
  12. Inês Nogueira; Francisca Dias; Morais, Mariana; Ana Luísa Teixeira; Rui Medeiros. "Resistência ao Everolimus em carcinoma de células renais de células claras: influência do miRNA-101 e do HIF-2a". Paper presented in 1º Encontro Nacional de Jovens Investigadores em Oncologia, 2019.
Journal article
  1. Tavares, Inês; Morais, Mariana; Dias, Francisca; Medeiros, Rui; Teixeira, Ana Luísa. "Deregulated miRNAs in enzalutamide resistant prostate cancer: A comprehensive review of key molecular alterations and clinical outcomes". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1879 2 (2024): 189067. http://dx.doi.org/10.1016/j.bbcan.2023.189067.
    10.1016/j.bbcan.2023.189067
  2. Morais, Mariana; Machado, Vera; Figueiredo, Patrícia; Dias, Francisca; Craveiro, Rogéria; Lencart, Joana; Palmeira, Carlos; et al. "Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma". Antioxidants 12 12 (2023): 2051. http://dx.doi.org/10.3390/antiox12122051.
    Published • 10.3390/antiox12122051
  3. Almeida, Cristina; Teixeira, Ana Luísa; Dias, Francisca; Morais, Mariana; Medeiros, Rui. "Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management". Biology 12 5 (2023): 665. http://dx.doi.org/10.3390/biology12050665.
    10.3390/biology12050665
  4. Vera Machado; Mariana Morais; Rui Medeiros. "Hyaluronic Acid-Based Nanomaterials Applied to Cancer: Where Are We Now?". Pharmaceutics (2022): https://doi.org/10.3390/pharmaceutics14102092.
    10.3390/pharmaceutics14102092
  5. Morais, Mariana; Machado, Vera; Dias, Francisca; Figueiredo, Patrícia; Palmeira, Carlos; Martins, Gabriela; Fernandes, Rui; et al. "Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells". International Journal of Nanomedicine Volume 17 (2022): 4321-4337. http://dx.doi.org/10.2147/ijn.s364862.
    Published • 10.2147/ijn.s364862
  6. Cristina Almeida; Ana Luísa Teixeira; Francisca Dias; Vera Machado; Mariana Morais; Gabriela Martins; Carlos Palmeira; et al. "Extracellular Vesicles Derived-LAT1 mRNA as a Powerful Inducer of Colorectal Cancer Aggressive Phenotype". Biology (2022): https://doi.org/10.3390/biology11010145.
    10.3390/biology11010145
  7. Mariana Morais; Francisca Dias; Inês Nogueira; Anabela Leão; Nuno Gonçalves; Luís Araújo; Sara Granja; et al. "Cancer Cells’ Metabolism Dynamics in Renal Cell Carcinoma Patients’ Outcome: Influence of GLUT-1-Related hsa-miR-144 and hsa-miR-186". Cancers 13 7 (2021): 1733-1733. https://doi.org/10.3390/cancers13071733.
    10.3390/cancers13071733
  8. Francisca Dias; Cristina Almeida; Ana Luísa Teixeira; Mariana Morais; Rui Medeiros. "LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression". Biomedicines 9 2 (2021): 195-195. https://doi.org/10.3390/biomedicines9020195.
    10.3390/biomedicines9020195
  9. Morais, Mariana; Machado, Vera; Dias, Francisca; Palmeira, Carlos; Martins, Gabriela; Fonseca, Magda; Martins, Catarina S. M.; et al. "Starch-Capped AgNPs’ as Potential Cytotoxic Agents against Prostate Cancer Cells". Nanomaterials 11 2 (2021): 256. http://dx.doi.org/10.3390/nano11020256.
    Published • 10.3390/nano11020256
  10. Morais, Mariana; Teixeira, Ana Luísa; Dias, Francisca; Machado, Vera; Medeiros, Rui; Prior, João A. V.. "Cytotoxic Effect of Silver Nanoparticles Synthesized by Green Methods in Cancer". Journal of Medicinal Chemistry 63 23 (2020): 14308-14335. http://dx.doi.org/10.1021/acs.jmedchem.0c01055.
    Published • 10.1021/acs.jmedchem.0c01055
  11. Dias, Francisca; Teixeira, Ana Luísa; Nogueira, Inês; Morais, Mariana; Maia, Joana; Bodo, Cristian; Ferreira, Marta; et al. "Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease". Cancers 12 6 (2020): 1450. http://dx.doi.org/10.3390/cancers12061450.
    Published • 10.3390/cancers12061450
  12. Francisca Dias; Ana L Teixeira; Inês Nogueira; Mariana Gomes Morais; Joana Maia; Cristian Bodo; Marta Ferreira; et al. "Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study". International Journal of Molecular Sciences (2020): https://www.mdpi.com/1422-0067/21/13/4624.
    10.3390/ijms21134624
  13. Morais, Mariana; Dias, Francisca; Resende, Telma; Nogueira, Inês; Oliveira, Jorge; Maurício, Joaquina; Teixeira, Ana Luísa; Medeiros, Rui. "Leukocyte telomere length and hTERT genetic polymorphism: influence in renal cell carcinoma clinical outcome". Future Oncology (2020):
    Published
  14. Morais, Mariana; Dias, Francisca; Teixeira, Ana Luísa; Medeiros, Rui. "

    Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney

    ". Cancer Management and Research Volume 12 (2020): 1669-1679. http://dx.doi.org/10.2147/cmar.s211225.
    10.2147/cmar.s211225
  15. Barros, Bela; Morais, Mariana; Teixeira, Ana Luísa; Medeiros, Rui. "Loss of Chromosome Y and Its Potential Applications as Biomarker in Health and Forensic Sciences". Cytogenetic and Genome Research 160 5 (2020): 225-237. http://dx.doi.org/10.1159/000508564.
    10.1159/000508564
  16. Nogueira, Inês; Dias, Francisca; Morais, Mariana; Teixeira, Ana Luísa; Medeiros, Rui. "Everolimus resistance in clear cell renal cell carcinoma: miRNA-101 and HIF-2a as molecular triggers?". Future Oncology 15 20 (2019): 2361-2370. http://dx.doi.org/10.2217/fon-2019-0067.
    Published • 10.2217/fon-2019-0067
  17. Dias, Francisca; Morais, Mariana; Teixeira, Ana; Medeiros, Rui. "Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior". Cancers 10 10 (2018): 381. http://dx.doi.org/10.3390/cancers10100381.
    Published • 10.3390/cancers10100381
  18. Morais M; Dias F; Teixeira AL; Medeiros R. "MicroRNAs and altered metabolism of clear cell renal cell carcinoma: Potential role as aerobic glycolysis biomarkers.". Biochimica et biophysica acta (2017): http://europepmc.org/abstract/med/28579513.
    10.1016/j.bbagen.2017.05.028
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2022/11/18 Glucose-Functionalized Silver Nanoparticles as a Potential New Therapy Agent Targeting Hormone-Resistant Prostate Cancer cells Annual Meeting of the Portuguese Microscopy Society
(Portugal)
2021/09/24 Silver Nanoparticles functionalized with glucose as potential therapeutic agents in Prostate Cancer resistant to Androgen Deprivation Therapy 3º Encontro Nacional de Jovens Investigadores em Oncologia
Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte (Porto, Portugal) (Oporto, Portugal)
2020/09/24 "The cytotoxic potential of silver nanoparticles against hormonal resistant Prostate Cancer cells" 2º Encontro de Jovens Investigadores
Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte (Porto, Portugal) (Portugal)
2019/11/29 O potencial citotóxico de nanopartículas de prata com capping de amido no Cancro da Próstata Resistente à Castração 16º Congresso Nacional de Oncologia
Sociedade Portuguesa de Oncologia (Estoril, Portugal)
2018/02 GLUT-1 related microRNAs and Glycolysis in Clear Cell Renal Cell Carcinoma IJUP'18 - 11º Encontro de Jovens Investigadores da Univsersidade do Porto
Universidade do Porto (Porto, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2021/01 - Current O Efeito de Warbug no processo de aquisição de resistência à terapia hormonal em células de cancro da próstata
Co-supervisor
 Bioquímica (Degree)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/09 - 2018/11 Marcadores moleculares associados ao envelhecimento
Co-supervisor
 Medicina Legal (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2015 - 2015 Organization Comitee Member of Joarnadas de Bioquímica II (2015 - 2015)
Congress (Member of the Organising Committee)
 Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2019/10/18 - 2019/10/18 Attendance in the Conference New Frontiers in Uro-Oncology
Conference
2019/10/12 - 2019/10/12 Attendance in the course: Imunoterapia no Carcinoma de Células Renais Metastizado
Grupo Português de Genito-Urinários, Portugal
2019/09 - 2019/10 Attendance in the Course "Introdução à Investigação"
Escola Portuguesa de Oncologia do Porto, Portugal
2019/09/27 - 2019/09/27 Attendance on the Workshop “Extracellular Vesicles”
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2019/05/02 - 2019/05/03 Attendance in the 26th Porto Cancer Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2018/11/09 - 2018/11/10 Attendance in the 3º Congresso Nacional de Prevenção Oncológica e Direitos dos Doentes
Congress
 3º Congresso Nacional de Prevenção Oncológica e Direitos dos Doentes
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2018/06/13 - 2018/06/13 Attendence in the Conference "Viver mais e melhor com Cancro?"
Conference
 "Viver mais e melhor com Cancro?"
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2018/04/18 - 2018/04/18 Attendance in the Conference "Imuno-oncologia: tratamentos inovadores"
Conference
 "Imuno-oncologia: tratamentos inovadores"
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2018/01/08 - 2018/01/12 Attendance in International Intensive Course on Cancer Biology: Advances in Epidemiology, Etiology & Therapy
Other
 International Intensive Course on Cancer Biology: Advances in Epidemiology, Etiology & Therapy
Universidade do Porto Faculdade de Farmácia, Portugal
2018 - 2018 Attendance in Workshop: “NGS (Next Generation Sequencing): Nova abordagem no Diagnóstico Oncológico."
Workshop
 Workshop: “NGS (Next Generation Sequencing): Nova abordagem no Diagnóstico Oncológico.”
Quilaban Academy 2018, Portugal
2017/05/19 - 2017/05/19 Attendance in 2nd Porto Precision Oncology Meeting From Basic Research to Clinical Practice 2nd Porto Precision Oncology Meeting From Basic Research to Clinical Practice
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2017/05/11 - 2017/05/12 Attendance in 24th Porto Cancer Meeting
Congress
 24th Porto Cancer Meeting
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2017 - 2017 Attendance in Translating Colorectal Cancer Research Workshop
Workshop
 Translating Colorectal Cancer Research Workshop
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2016/04/28 - 2016/04/29 Attendance in 2nd ASPIC International Congress
Congress
 2nd ASPIC International Congress
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2016 - 2016 Attendance in Jornadas da Bioquímica III
Congress
 Jornadas da Bioquímica III
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2015 Attendance in III AEICBAS Biomedical Congress
Congress
 III AEICBAS Biomedical Congress
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2015 Attendance in GABBA Mini-Symposium: T cell Activation
Symposium
 GABBA Mini-Symposium: T cell Activation
Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2015 - 2015 Attendance in Workshop: “Molecular Gastronomy – from the lab to the kitchen”
Workshop
 Workshop: “Molecular Gastronomy – from the lab to the kitchen”
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015 - 2015 Attendance in Workshop: “Cosmetology: what’s being done in the laboratory in the cosmetic industry”
Workshop
 Workshop: “Cosmetology: what’s being done in the laboratory in the cosmetic industry”
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2014 Attendance in GABBA Annual Symposium 2014
Symposium
 GABBA Annual Symposium 2014
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2014 Attendance in Jornadas da Bioquímica I
Congress
 Jornadas da Bioquímica I
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2014 XIV Curso de Medicina Legal e Outras Ciências Forenses
Other
 XIV Curso de Medicina Legal e Outras Ciências Forenses
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Association member

Society Organization name Role
2019/09 - Current MEERU | Abrir Caminho
2016/09 - 2018/09 O Grão Director
2016/07 - 2016/09 O Grão Missão Humanitária em Moçambique (Lifidzi, Tete)

Mentoring / Tutoring

Topic Student name
2018/10 - 2019/09 Orientação do trabalho laboratorial Ana Bela Coelho Barros
Distinctions

Award

2022 Menção Honrosa
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2019 Prémio Melhor Poster 1º Lugar, 11º Simpósio em Metabolismo
Centro de Investigação Médica da Faculdade de Medicina da Universidade do Porto, Portugal

Other distinction

2020 Bolsa de Doutoramento
Fundação para a Ciência e a Tecnologia, Portugal
2017 Bolsa de Investigação
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal